These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11738609)

  • 1. Medium-dependence of the secondary structure of exendin-4 and glucagon-like-peptide-1.
    Andersen NH; Brodsky Y; Neidigh JW; Prickett KS
    Bioorg Med Chem; 2002 Jan; 10(1):79-85. PubMed ID: 11738609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exendin-4 and glucagon-like-peptide-1: NMR structural comparisons in the solution and micelle-associated states.
    Neidigh JW; Fesinmeyer RM; Prickett KS; Andersen NH
    Biochemistry; 2001 Nov; 40(44):13188-200. PubMed ID: 11683627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cloning of the helodermin and exendin-4 cDNAs in the lizard. Relationship to vasoactive intestinal polypeptide/pituitary adenylate cyclase activating polypeptide and glucagon-like peptide 1 and evidence against the existence of mammalian homologues.
    Pohl M; Wank SA
    J Biol Chem; 1998 Apr; 273(16):9778-84. PubMed ID: 9545315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors.
    Al-Sabah S; Donnelly D
    Br J Pharmacol; 2003 Sep; 140(2):339-46. PubMed ID: 12970080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Black widow spider alpha-latrotoxin: a presynaptic neurotoxin that shares structural homology with the glucagon-like peptide-1 family of insulin secretagogic hormones.
    Holz GG; Habener JF
    Comp Biochem Physiol B Biochem Mol Biol; 1998 Oct; 121(2):177-84. PubMed ID: 9972293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The primary ligand-binding interaction at the GLP-1 receptor is via the putative helix of the peptide agonists.
    Al-Sabah S; Donnelly D
    Protein Pept Lett; 2004 Feb; 11(1):9-14. PubMed ID: 14965273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Truncated Glucagon-like Peptide-1 and Exendin-4 α-Conotoxin pl14a Peptide Chimeras Maintain Potency and α-Helicity and Reveal Interactions Vital for cAMP Signaling in Vitro.
    Swedberg JE; Schroeder CI; Mitchell JM; Fairlie DP; Edmonds DJ; Griffith DA; Ruggeri RB; Derksen DR; Loria PM; Price DA; Liras S; Craik DJ
    J Biol Chem; 2016 Jul; 291(30):15778-87. PubMed ID: 27226591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The isolated N-terminal domain of the glucagon-like peptide-1 (GLP-1) receptor binds exendin peptides with much higher affinity than GLP-1.
    López de Maturana R; Willshaw A; Kuntzsch A; Rudolph R; Donnelly D
    J Biol Chem; 2003 Mar; 278(12):10195-200. PubMed ID: 12524435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta).
    Young AA; Gedulin BR; Bhavsar S; Bodkin N; Jodka C; Hansen B; Denaro M
    Diabetes; 1999 May; 48(5):1026-34. PubMed ID: 10331407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High potency antagonists of the pancreatic glucagon-like peptide-1 receptor.
    Montrose-Rafizadeh C; Yang H; Rodgers BD; Beday A; Pritchette LA; Eng J
    J Biol Chem; 1997 Aug; 272(34):21201-6. PubMed ID: 9261127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exenatide: NMR/CD evaluation of the medium dependence of conformation and aggregation state.
    Hudson FM; Andersen NH
    Biopolymers; 2004; 76(4):298-308. PubMed ID: 15386269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-specific expression of unique mRNAs that encode proglucagon-derived peptides or exendin 4 in the lizard.
    Chen YE; Drucker DJ
    J Biol Chem; 1997 Feb; 272(7):4108-15. PubMed ID: 9020121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR studies of the aggregation of glucagon-like peptide-1: formation of a symmetric helical dimer.
    Chang X; Keller D; O'Donoghue SI; Led JJ
    FEBS Lett; 2002 Mar; 515(1-3):165-70. PubMed ID: 11943215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential structural properties of GLP-1 and exendin-4 determine their relative affinity for the GLP-1 receptor N-terminal extracellular domain.
    Runge S; Schimmer S; Oschmann J; Schiødt CB; Knudsen SM; Jeppesen CB; Madsen K; Lau J; Thøgersen H; Rudolph R
    Biochemistry; 2007 May; 46(19):5830-40. PubMed ID: 17444618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain.
    Runge S; Thøgersen H; Madsen K; Lau J; Rudolph R
    J Biol Chem; 2008 Apr; 283(17):11340-7. PubMed ID: 18287102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Met-204 and Tyr-205 are together important for binding GLP-1 receptor agonists but not their N-terminally truncated analogues.
    López de Maturana R; Treece-Birch J; Abidi F; Findlay JB; Donnelly D
    Protein Pept Lett; 2004 Feb; 11(1):15-22. PubMed ID: 14965274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.
    Parkes DG; Pittner R; Jodka C; Smith P; Young A
    Metabolism; 2001 May; 50(5):583-9. PubMed ID: 11319721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of glucagon-like peptide (7-36) amide in a dodecylphosphocholine micelle as determined by 2D NMR.
    Thornton K; Gorenstein DG
    Biochemistry; 1994 Mar; 33(12):3532-9. PubMed ID: 8142350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational analysis of a set of peptides corresponding to the entire primary sequence of the N-terminal domain of the ribosomal protein L9: evidence for stable native-like secondary structure in the unfolded state.
    Luisi DL; Wu WJ; Raleigh DP
    J Mol Biol; 1999 Mar; 287(2):395-407. PubMed ID: 10080901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide-1 synthetic analogs: new therapeutic agents for use in the treatment of diabetes mellitus.
    Holz GG; Chepurny OG
    Curr Med Chem; 2003 Nov; 10(22):2471-83. PubMed ID: 14529486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.